Brian Dake
Overview
Explore the profile of Brian Dake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
73
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davidson E, Coppey L, Dake B, Yorek M
Exp Diabetes Res
. 2011 Aug;
2011:810469.
PMID: 21822422
We sought to determine the effect of dipeptidyl peptidase IV (DPP-IV) inhibition on streptozotocin diabetes-induced vascular and neural dysfunction. After 4 weeks of untreated diabetes, rats were treated for 12...
2.
Davidson E, Coppey L, Holmes A, Dake B, Yorek M
Eur J Pharmacol
. 2011 Aug;
668(3):497-506.
PMID: 21816138
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril (an inhibitor of neutral endopeptidase and angiotensin converting enzyme (ACE)) improves vascular...
3.
Oltman C, Davidson E, Coppey L, Kleinschmidt T, Dake B, Yorek M
Eur J Pharmacol
. 2010 Nov;
650(2-3):556-62.
PMID: 21040718
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril (an inhibitor of neutral endopeptidase and angiotensin converting enzyme (ACE)) improves vascular...
4.
Davidson E, Coppey L, Dake B, Yorek M
J Obes
. 2010 Sep;
2011.
PMID: 20847891
The objective of this study was to determine the effect of AVE7688, a drug that inhibits both angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) activity, on neural and vascular...